Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers show a genetic overlap in schizophrenia and cognitive ability

17.12.2013
Investigators at The Feinstein Institute for Medical Research have discovered for the first time, direct evidence of a genetic overlap between schizophrenia and general cognitive ability. The findings are published online in Molecular Psychiatry.

Schizophrenia is a chronic, severe and disabling brain disorder that affects approximately 2.2 million Americans each year. It is characterized by a significant reduction in general cognitive abilities, so that many patients struggle with completing school, holding jobs and achieving their full potential.

Previous studies have indicated subtle cognitive abnormalities in undiagnosed and unmedicated relatives of patients who live with schizophrenia, which suggests the possibility of genetic overlap between risk for schizophrenia and cognitive traits. These previous studies, however, did not test this overlap on the molecular level.

Anil Malhotra, MD, director of psychiatry research at Zucker Hillside Hospital and an investigator at the Feinstein Institute, and his colleague Todd Lencz, PhD, associate investigator at the Zucker Hillside Hospital and the Feinstein Institute, conducted the first molecular genetic test to determine if genetic markers of reduced cognitive ability were also genetic markers of increased schizophrenia risk. Specifically, they conducted a large-scale, meta-analysis, genome-wide association study (GWAS) of samples from 5,000 subjects provided by the Cognitive Genomics consorTium (COGENT). COGENT, which was founded and is led by Dr. Malhotra, is an international consortium of nine teams of researchers across seven countries.

Through their analysis, they confirmed that patients who suffered from schizophrenia also had lessened cognitive ability. This is the first direct evidence for genetic overlap between schizophrenia risk genes and genes that regulate general cognitive ability, such as memory, attention, and language abilities. The results provide molecular confirmation of this genetic overlap and additional insight into how schizophrenia develops and progresses.

"This research leads us to a deeper understanding of how schizophrenia affects the brain at the molecular level," said Dr. Lencz. "Our studies are designed to provide clues to the development of new treatments to improve the lives of our patients."

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers.

Emily Ng | EurekAlert!
Further information:
http://www.FeinsteinInstitute.org
http://www.nshs.edu

More articles from Health and Medicine:

nachricht Gym Culture Likened to McDonalds
23.04.2014 | University of Gothenburg

nachricht Drug-related morbidity in more than 10% of adults
23.04.2014 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Siemens at the 2014 UIC ERTMS World Conference in Istanbul

01.04.2014 | Event News

AERA Meeting: German and US-American educational researchers in dialogue

28.03.2014 | Event News

WHS Regional Meeting: International experts address health challenges in Latin America

24.03.2014 | Event News

 
Latest News

TWO in ONE Cable from SAB presented at the exhibition AUTOMATICA from 03.-06. Juni 2014 (Hall B4, Stand 105)

23.04.2014 | Trade Fair News

EMBO Gold Medal 2014 awarded to Sophie Martin

23.04.2014 | Awards Funding

UA Researcher and Colleagues Discover the Birthplace of the Chili Pepper

23.04.2014 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>